ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer
Dr Abel Centurion speaks to ecancer about his recent case report and review of systemic treatment of renal liposarcoma.
He initially talks about what the case report investigated. He says liposarcomas are malignant mesenchymal tumours usually located in the retroperitoneum and they rarely occurring as a single lesion in the kidney.
Dr Centurion says that in this paper they represented a case of a 59-year-old male patient with a left renal mass detected by computed tomography scan. He underwent radical nephrectomy and the histopathological study reported a primary undifferentiated liposarcoma of the kidney without nodal involvement.
Dr Centurion explains that the objective of this report was to present a case and literature review with current evidence of treatment options and prognostic factors for survival. He also talks about the future of this study.
Read the full article here on ecancermedicalscience.
ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer
ASCO 2024: Lung cancer highlights
Treatment of multiple myeloma in Turkey
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
Multiple myeloma in a resource constrained setting
Somatic mutation profile of breast cancer in Uganda
Choosing Wisely in pathology
Choosing Wisely in radiology Tanzania
Targeting BRAF V600E in metastatic colorectal cancer: where are we today?